Skip to main content

Table 1 Effect of ENX on baseline body weight, heart weight and the ratio of the heart to body weight

From: Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis

Group Baseline BW(g) Terminal BW (g) Heart weight (g) Heart/BW
Control n = 7 196 ± 10 205 ± 8 0.83 ± 0.054 4.1 ± 0.23
DOX n = 6 202 ± 14 177 ± 12 0.65 ± 0.278a 3.7 ± 0.21
ENX plus DOX n = 6 216 ± 10 194 ± 5 0.71 ± 0.25 3.6 ± 0.10
  1. BW body weight. Data is expressed as mean ± SEM. a P ≤ 0.05 for DOX vs. control (analyzed by one-way ANOVA followed by Fisher’s least significant difference (LSD) test)